Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rocio Alvarez

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Cellular and Molecular Gastroenterology and Hepatology|April 8, 2023
PTPN2 Is a Critical Regulator of Ileal Paneth Cell Viability and Function in MiceVinicius Canale, Marianne R Spalinger, Rocio Alvarez, et al.
Cancers|January 8, 2023
Large Cancer Pedigree Involving Multiple Cancer Genes including Likely Digenic <i>MSH2</i> and <i>MSH6</i> Lynch Syndrome (LS) and an Instance of Recombinational Rescue from LSIngrid P Vogelaar, Stephanie Greer, Fan Wang, et al.
Frontiers in Microbiology|January 9, 2019
Relationship Between the Quorum Network (Sensing/Quenching) and Clinical Features of Pneumonia and Bacteraemia Caused by <i>A. baumannii</i>Laura Fernandez-Garcia, Antón Ambroa, Lucia Blasco, et al.
Familial Cancer|July 27, 2025
MLH1 c.27G>A (p.Arg9=) is a synonymous likely/pathogenic variant underlying variably mosaic constitutional MLH1 methylation in Lynch syndromeRocio Alvarez, Paula Climent-Cantó, GiWon Shin, et al.
Gynecologic Oncology|March 9, 2023
MLH1-methylated endometrial cancer under 60 years of age as the "sentinel" cancer in female carriers of high-risk constitutional MLH1 epimutationMegan P Hitchins, Rocio Alvarez, Lisa Zhou, et al.
Familial Cancer|January 31, 2026
Germline MLH1 c.-42 C > T is a likely pathogenic variant predisposing to a reduced-penetrance/modified Lynch syndrome phenotype featuring MLH1-methylated cancersDaniel D Buchanan, Rocio Alvarez, Khalid Mahmood, et al.
The Journal of Clinical Investigation|October 8, 2021
T cell protein tyrosine phosphatase protects intestinal barrier function by restricting epithelial tight junction remodelingRonald R Marchelletta, Moorthy Krishnan, Marianne R Spalinger, et al.
BMJ Open Gastroenterology|July 6, 2019
Methylated <i>SEPTIN9</i> plasma test for colorectal cancer detection may be applicable to Lynch syndromeMegan P Hitchins, Ingrid P Vogelaar, Kevin Brennan, et al.
The Journal of Headache and Pain|November 22, 2023
Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registryVictor Obach, Fernando Velasco, Rocio Alvarez Escudero, et al.
Neurology|January 28, 2026
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA CohortEdoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Cellular and Molecular Gastroenterology and Hepatology|April 8, 2023
PTPN2 Is a Critical Regulator of Ileal Paneth Cell Viability and Function in MiceVinicius Canale, Marianne R Spalinger, Rocio Alvarez, et al.
Cancers|January 8, 2023
Large Cancer Pedigree Involving Multiple Cancer Genes including Likely Digenic <i>MSH2</i> and <i>MSH6</i> Lynch Syndrome (LS) and an Instance of Recombinational Rescue from LSIngrid P Vogelaar, Stephanie Greer, Fan Wang, et al.
Frontiers in Microbiology|January 9, 2019
Relationship Between the Quorum Network (Sensing/Quenching) and Clinical Features of Pneumonia and Bacteraemia Caused by <i>A. baumannii</i>Laura Fernandez-Garcia, Antón Ambroa, Lucia Blasco, et al.
Familial Cancer|July 27, 2025
MLH1 c.27G>A (p.Arg9=) is a synonymous likely/pathogenic variant underlying variably mosaic constitutional MLH1 methylation in Lynch syndromeRocio Alvarez, Paula Climent-Cantó, GiWon Shin, et al.
Gynecologic Oncology|March 9, 2023
MLH1-methylated endometrial cancer under 60 years of age as the "sentinel" cancer in female carriers of high-risk constitutional MLH1 epimutationMegan P Hitchins, Rocio Alvarez, Lisa Zhou, et al.
Familial Cancer|January 31, 2026
Germline MLH1 c.-42 C > T is a likely pathogenic variant predisposing to a reduced-penetrance/modified Lynch syndrome phenotype featuring MLH1-methylated cancersDaniel D Buchanan, Rocio Alvarez, Khalid Mahmood, et al.
The Journal of Clinical Investigation|October 8, 2021
T cell protein tyrosine phosphatase protects intestinal barrier function by restricting epithelial tight junction remodelingRonald R Marchelletta, Moorthy Krishnan, Marianne R Spalinger, et al.
BMJ Open Gastroenterology|July 6, 2019
Methylated <i>SEPTIN9</i> plasma test for colorectal cancer detection may be applicable to Lynch syndromeMegan P Hitchins, Ingrid P Vogelaar, Kevin Brennan, et al.
The Journal of Headache and Pain|November 22, 2023
Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registryVictor Obach, Fernando Velasco, Rocio Alvarez Escudero, et al.
Neurology|January 28, 2026
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA CohortEdoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo, et al.
Pageof 4